| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Manufacturing | 6/06/2025 |
| fampridine | Tablet, modified release | 10 mg | Resolved | Available | Manufacturing | 6/06/2025 |
| bicalutamide | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 6/06/2025 |
| azithromycin dihydrate | Tablet, film coated | 524.05 mg | Resolved | Available | Manufacturing | 6/06/2025 |
| ondansetron | Tablet, orally disintegrating | 8 mg | Resolved | Available | Manufacturing | 6/06/2025 |
| acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 6/06/2025 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Anticipated | Available | Manufacturing | 6/06/2025 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 6/06/2025 |
| alprazolam | Tablet, uncoated | 2 mg | Current | Limited Availability | Manufacturing | 6/06/2025 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 6/06/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Unavailable | Manufacturing | 6/06/2025 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| venlafaxine | Capsule, modified release | 150 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| omega3acid ethyl esters 90 | Capsule, soft | 1000 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| vincristine sulfate | Injection, solution | 1 mg/mL | Anticipated | Available | Manufacturing | 5/06/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Anticipated | Available | Manufacturing | 5/06/2025 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 320 mg~25 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| hydrochlorothiazide~valsartan | Tablet, film coated | 12.5 mg~160 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| ropivacaine hydrochloride | Injection, solution | 150 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/06/2025 |
| risperidone | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| capecitabine | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 5/06/2025 |
| simvastatin~ezetimibe | Tablet | 20 mg~10 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| irinotecan hydrochloride trihydrate | Injection, concentrated | 100 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| carboplatin | Injection, solution | 450 mg | Resolved | Available | Manufacturing | 5/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .375 mg | Resolved | Available | Manufacturing | 5/06/2025 |
| sodium iodide(131I) | Oral Liquid, solution | 50 MBq | Resolved | Available | Manufacturing | 5/06/2025 |
| sodium iodide(131I) | Capsule, hard | 50 MBq | Resolved | Available | Manufacturing | 5/06/2025 |
| live varicella vaccine | Injection, powder for | 4000 PFU/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 5/06/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 5/06/2025 |
| betamethasone dipropionate~calcipotriol | Foam | 264 microgram/g~20.5 microgram/g | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 5/06/2025 |
| mupirocin | Ointment | 20 mg/g | Resolved | Available | Unexpected increase in consumer demand | 5/06/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Resolved | Available | Manufacturing | 5/06/2025 |
| olanzapine | Tablet, uncoated | 5 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| deferasirox | Tablet, film coated | 90 mg | Current | Limited Availability | Manufacturing | 5/06/2025 |
| deferasirox | Tablet, film coated | 360 mg | Anticipated | Available | Manufacturing | 5/06/2025 |
| lanreotide acetate | Injection, solution | 133.33 mg | Anticipated | Available | Manufacturing | 5/06/2025 |
| metoclopramide hydrochloride monohydrate | Injection, solution | 10.54 mg | Anticipated | Available | Unexpected increase in consumer demand | 5/06/2025 |
| sodium iodide(131I) | Oral Liquid, solution | 1201 MBq | Resolved | Available | Manufacturing | 5/06/2025 |
| sodium pertechnetate(99mTc) | Injection, solution | 20 GBq | Resolved | Available | Manufacturing | 5/06/2025 |
| sodium pertechnetate(99mTc) | Injection | 370 GBq | Resolved | Available | Manufacturing | 5/06/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/06/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/06/2025 |
| prilocaine~lidocaine | Gel | 42.5 mg~42.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 4/06/2025 |
| monobasic potassium phosphate | Injection, concentrated | 136.1 mg/mL | Resolved | Available | Manufacturing | 4/06/2025 |
| mirtazapine | Tablet, film coated | 45 mg | Current | Unavailable | Manufacturing | 4/06/2025 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 4/06/2025 |
| duloxetine hydrochloride | Capsule, enteric | 33.66 mg | Resolved | Available | Unexpected increase in consumer demand | 4/06/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, modified release | .75 mg | Anticipated | Available | Manufacturing | 4/06/2025 |
| azacitidine | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 4/06/2025 |
| irbesartan | Tablet, film coated | 75 mg | Anticipated | Available | Manufacturing | 4/06/2025 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~150 mg | Anticipated | Available | Manufacturing | 4/06/2025 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Commercial Changes / Commercial viability | 4/06/2025 |
| avibactam sodium~ceftazidime pentahydrate | Injection, powder for | 543.5 mg~2329.7 mg | Anticipated | Available | Unexpected increase in consumer demand | 4/06/2025 |
| gefitinib | Tablet, film coated | 250 mg | Resolved | Available | Manufacturing | 4/06/2025 |
| metoprolol tartrate | Tablet, uncoated | 50 mg | Resolved | Available | Manufacturing | 4/06/2025 |
| foscarnet sodium | Injection, solution | 24 mg/mL | Resolved | Available | Manufacturing | 4/06/2025 |
| rivaroxaban | Tablet, film coated | 2.5 mg | Current | Unavailable | Unexpected increase in consumer demand | 4/06/2025 |
| rivaroxaban | Tablet, film coated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 4/06/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/06/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 4/06/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 4/06/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.96 mg | Current | Unavailable | Manufacturing | 4/06/2025 |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Resolved | Available | Unexpected increase in consumer demand | 3/06/2025 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/06/2025 |
| ramipril | Capsule, hard | 5 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| fluorouracil | Injection, solution | 5000 mg | Current | Unavailable | Unexpected increase in consumer demand | 3/06/2025 |
| exemestane | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| oxazepam | Tablet, uncoated | 15 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| perindopril erbumine | Tablet | 8 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 200 mg~54 mg~200 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 100 mg~27 mg~200 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 40.5 mg~200 mg~150 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| rizatriptan benzoate | Wafer | 14.53 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/06/2025 |
| flecainide acetate | Tablet, uncoated | 50 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| flecainide acetate | Tablet, uncoated | 100 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| rifampicin | Capsule | 300 mg | Current | Emergency Supply Only | Manufacturing | 3/06/2025 |
| dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Current | Unavailable | Manufacturing | 3/06/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Unexpected increase in consumer demand | 3/06/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| solifenacin succinate | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| lacosamide | Tablet, film coated | 100 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| rivaroxaban | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 3/06/2025 |
| buprenorphine hydrochloride | Tablet, uncoated | .216 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| methylphenidate hydrochloride | Capsule, hard | 10 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 3/06/2025 |
| oxazepam | Tablet, uncoated | 30 mg | Current | Unavailable | Manufacturing | 3/06/2025 |
| levothyroxine sodium | Tablet | 75 microgram | Current | Unavailable | Manufacturing | 3/06/2025 |
| rivaroxaban | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 3/06/2025 |
| suxamethonium chloride dihydrate | Injection, solution | 100 mg | Resolved | Available | Manufacturing | 2/06/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Resolved | Available | Manufacturing | 2/06/2025 |
2025年6月9日